UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000027668
Receipt No. R000030984
Scientific Title Evaluation of the new 22-gauge EUS guided Biopsy Needle (Acqiure) Comparing to another new 20-gauge FNA needle with forward-cutting bevel (ProCore) in Patients With Autoimmune Pancreatitis : A Prospective Randomized, Controlled Multicenter Study
Date of disclosure of the study information 2017/08/01
Last modified on 2019/08/04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Evaluation of the new 22-gauge EUS guided Biopsy Needle (Acqiure) Comparing to another new 20-gauge FNA needle with forward-cutting bevel (ProCore) in Patients With Autoimmune Pancreatitis : A Prospective Randomized, Controlled Multicenter Study
Acronym Comparing the diagnostic yield of EUS-FNA using ProCore and Acquire in patients with AIP (COMPAS study)
Scientific Title Evaluation of the new 22-gauge EUS guided Biopsy Needle (Acqiure) Comparing to another new 20-gauge FNA needle with forward-cutting bevel (ProCore) in Patients With Autoimmune Pancreatitis : A Prospective Randomized, Controlled Multicenter Study
Scientific Title:Acronym Comparing the diagnostic yield of EUS-FNA using ProCore and Acquire in patients with AIP (COMPAS study)
Region
Japan

Condition
Condition type 1 autoimmune pancreatitis
Classification by specialty
Medicine in general Gastroenterology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to test the hypothesis that modification of EUS needle design has a tangible impact on tissue acquisition performance in the setting of solid lesions of the pancreas. To this end, we compared the diagnostic performance and sample adequacy of 2 EUS core needles with differing tip, bevel, and sheath designs in a large, single- center cohort of patients with solid pancreatic masses.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Phase III

Assessment
Primary outcomes Diagnostic yield of the 22G Acquire and the 20G ProCore needle
Key secondary outcomes 1) Diagnostic accuracy and specificity of the 22G Acquire and the 20G ProCore needle
2) Contribution of histologic findings to the diagnosis of AIP according to the ICDC
3) Diagnostic sufficiency of Tissue obtained by the EUS needles
4) Evaluation of marked lymphoplasmacytic infiltration with fibrosis and without granulocytic infiltration.
5) Evaluation of abundant (>10 cells/HPF) IgG4-positive cells
6) storiform fibrosis
7) obliterative phlebitis
8) Success rate of EUS-FNA
9) Rate of complications related with EUS-FNA. the EUS needles
10) Comparing diagnostic accuracy of 1st pass and total passes in two groups, respectively.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 Acquire needle
Interventions/Control_2 ProCore needle
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with suspect of type 1 autoimmune pancreatitis
Agree to consent form
Patients with ECOG performance status 0 or 1
Key exclusion criteria 1) Uncorrectable coagulopathy (INR > 1.5). Or uncorrectable thrombocytopenia (platelet < 50,000)
2) Uncooperative patients
3) Inaccessible lesions to EUS
4) Patients with ASA criteria 3, 4, or 5
5) Refusal to consent form
Target sample size 110

Research contact person
Name of lead principal investigator
1st name AKira
Middle name
Last name Kurita
Organization Kitano Hospital, The Tazuke Kofukai Medical Research Institute
Division name Division of Gastroenterology and Hepatology, Digestive Disease Center
Zip code 530-8480
Address 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan.
TEL 06-6131-2662
Email kuritaaki1976@gmail.com

Public contact
Name of contact person
1st name Akira
Middle name
Last name Kurita
Organization Kitano Hospital, The Tazuke Kofukai Medical Research Institute
Division name Division of Gastroenterology and Hepatology, Digestive Disease Center
Zip code 530-8480
Address 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan.
TEL 06-6131-2662
Homepage URL
Email kuritaaki1976@gmail.com

Sponsor
Institute Bilio-Pancreatic Stenting study group
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kitano Hospital, The Tazuke Kofukai Medical Research Institute
Address 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan.
Tel 06-6131-2662
Email rinshou@kitano-hp.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪医科大学附属病院(大阪府)、関西医科大学附属病院(大阪府)、大阪市立大学医学部附属病院(大阪府)、近畿大学医学部附属病院(大阪府)、北野病院(大阪府)、大阪赤十字病院(大阪府)、天理よろづ相談所病院(奈良県)、神戸大学医学部附属病院(兵庫県)、川崎医科大学附属総合医療センター(岡山県)、福岡大学筑紫病院(福岡県)、宮崎大学医学部附属病院(宮崎県)、熊本大学医学部附属病院(熊本県)、和歌山県立医科大学附属病院(和歌山県)、京都大学医学部附属病院(京都府)、鹿児島大学医学部附属病院(鹿児島県)、大阪国際がんセンター(大阪府)、鳥取赤十字病院(鳥取県)、北播磨総合医療センター(兵庫県)、島根大学医学部附属病院(島根県)、京都桂病院(京都ふ)、京都府立医科大学附属病院(京都府)、広島赤十字・原爆病院(広島県)、久留米大学医学部附属病院(福岡県)、淀川キリスト教病院(大阪府)、済生会中津病院(大阪府)、香川大学医学部附属病院(香川県)、鳥取大学医学部附属病院(鳥取県)、ベルランド総合病院(大阪府)、大阪大学医学部附属病院(大阪府)、大阪市立総合医療センター(大阪府)、JA尾道総合病院(広島県)、日赤和歌山医療センター(和歌山県)

Other administrative information
Date of disclosure of the study information
2017 Year 08 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 110
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2017 Year 06 Month 06 Day
Date of IRB
Anticipated trial start date
2017 Year 08 Month 01 Day
Last follow-up date
2023 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2017 Year 06 Month 06 Day
Last modified on
2019 Year 08 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030984

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.